- Sort by:
- Browse by:
- Free
- audio + slides
Doing a biopharma start-up from academics
Laurence H. Hurley, D.Sc., Ph.D.
Univ. of Arizona, Tucson, AZ
- Free
- audio + slides
The evolving role of foundations in translating promising academic discoveries into breakthrough therapeutics
Louis J. DeGennaro, Ph.D.
The Leukemia and Lymphoma Society, White Plains, NY
- Free
- audio + slides
Novel epigenetic and microRNA drugs in cancer therapy
Manel Esteller, M.D., Ph.D.
Inst. d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain
- Free
- audio + slides
Recent developments of two NCI epigenetic drugs: Zebularine and 3-deazaneplanocin
Victor E. Marquez, Ph.D.
National Cancer Institute-Frederick, Frederick, MD
- Free
- audio + slides
Sirtuins as therapeutic targets in cancer
Antonio Bedalov, M.D., Ph.D.
Fred Hutchinson Cancer Research Center, Seattle, WA
- Free
- audio + slides
microRNA processing and target interactions
Dr. John J. Rossi
Beckman Research Institute, Duarte, CA
- Free
- audio + slides
Obesity, diabetes, and risk of prostate cancer: Results from cancer prevention trials
Scott M. Lippman, M.D.
UT M. D. Anderson Cancer Center, Houston, TX
- Free
- audio + slides
Chronic Inflammation Is a Link between Obesity, Cancer, and Nutrition
Bharat B. Aggarwal, Ph.D.
UT M. D. Anderson Cancer Center, Houston, TX
- Free
- audio + slides
From soup to nuts: Evaluating bioactive food components in breast cancer prevention trials
Karen A. Johnson, M.D., Ph.D.
National Cancer Institute, Bethesda, MD
- Free
- audio + slides
An evolving concept of cancer stem cells in tumor biology
Jeremy N. Rich, M.D.
The Cleveland Clinic, Cleveland, OH
- Free
- audio + slides
Strategies for targeting breast cancer stem cells and treatment resistance
Piyush Gupta, B.S.
Broad Inst. of MIT and Harvard, Cambridge, MA
- Free
- audio + slides
Pharmacokinetics in drug discovery
Michael Michaelides, Ph.D.
Abbott Laboratories, Abbott Park, IL
- Free
- audio + slides
Pharmacokinetic and pharmacodynamic considerations in translational development
Andrew P. Krivoshik, M.D., Ph.D.
Abbott Laboratories, Abbott Park, IL
- Free
- audio + slides
Pharmacokinetics in the clinical development of new anticancer agents: Where the rubber hits the road
Anthony W. Tolcher, M.D.
South Texas Accelerated Research Therapeutics, San Antonio, TX
- Free
- audio + slides
Regulatory perspective of the role of pharmacokinetics in drug discovery and development
Dr. Julie Bullock
Food and Drug Administration, Silver Spring, MD
- Free
- audio + slides
miRNA polymorphisms and cancer risk
Joanne B. Weidhaas, M.D., Ph.D.
Yale Univ. School of Medicine, New Haven, CT
- Free
- audio + slides
Oncogenic miRNAs in cancer and development
Andrea Ventura, M.D., Ph.D.
Memorial Sloan-Kettering Institute, New York, NY
- Free
- audio + slides
Functional dissection of a polycistronic miRNA oncogene in lymphomagenesis
Dr. Virginie Olive
University of California, Berkeley, CA
- Free
- audio + slides
The other side of posttranscriptional regulation of gene expression in cancer: Altered visibility of transcripts to microRNAs and RNA binding proteins via alternative cleavage and polyadenylation
Dr. Joel R. Neilson
Baylor College of Medicine, Houston, TX
- Free
- audio + slides
Mechanisms of site-specific metastasis to bone
Theresa A. Guise, M.D.
University of Virginia, Charlottesville, VA
- Free
- audio + slides
Signaling pathways regulating lung metastasis
Carrie W. Rinker-Schaeffer, Ph.D.
University of Chicago, Chicago, IL
- Free
- audio + slides
The tumor microenvironment in different stages of the hepatic metastasis process
Fernando Vidal-Vanaclocha, M.D., Ph.D.
Basque Country University School of Medicine, Bizkaia, Spain
- Free
- audio + slides
Brain metastasis: A unique microenvironment and a sanctuary from chemotherapy
Patricia S. Steeg, Ph.D.
National Cancer Institute, Bethesda, MD
- Free
- audio + slides
Roles of macrophages in cancer invasion and metastasis
Dr. Jeffrey W. Pollard
Albert Einstein College of Medicine, Bronx, NY
- Free
- audio + slides
Roles of bone marrow-derived cells in colon cancer metastasis
Makoto Mark Taketo, M.D., Ph.D.
Kyoto University Graduate School of Medicine, Kyoto, Japan